基本资料 投资组合 财务数据 基金公告
纳指生物科技ETF汇添富(513290) |
净值：
1.4724
|
日增长率：
0.02%
|
累计净值：1.4724 | 2026-05-11 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| GILD | 吉利德科学 | 122,601.00 | 118,231,105.34 | 7.82 |
| AMGN | 安进 | 47,046.00 | 114,537,763.01 | 7.58 |
| VRTX | 福泰制药 | 36,756.00 | 113,568,279.93 | 7.51 |
| REGN | 再生元制药 | 18,438.00 | 98,573,331.77 | 6.52 |
| ALNY | Alnylam Pharmaceuticals Inc | 23,535.00 | 53,881,543.90 | 3.56 |
| INSM | Insmed Inc | 38,251.00 | 43,279,487.48 | 2.86 |
| BIIB | 生化基因 | 26,044.00 | 33,037,689.13 | 2.19 |
| UTHR | 联合治疗 | 7,778.00 | 31,913,645.89 | 2.11 |
| ARGX | argenx SE ADR | 5,035.00 | 25,441,310.46 | 1.68 |
| RPRX | Royalty Pharma plc-A | 76,026.00 | 25,234,824.98 | 1.67 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2026-03-31 | 92.15 | - | 0.85 | 1,511,686,389.83 |
| 2025-12-31 | 88.22 | - | 0.58 | 1,511,183,771.80 |
| 2025-09-30 | 87.09 | - | 0.75 | 1,329,766,618.46 |
| 2025-06-30 | 85.33 | - | 0.68 | 1,276,255,394.75 |
| 2025-03-31 | 86.03 | - | 0.63 | 1,345,089,030.94 |
微信公众号
证券之星APP
